| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 06/17/2004 | WO2004050653A2 Oxime ester photoinitiators with heteroaromatic groups |
| 06/17/2004 | WO2004050651A1 Anilinopyrazole derivatives useful for the treatment of diabetes |
| 06/17/2004 | WO2004050650A1 Anilinopyrazole derivatives useful for the treatment of diabetes |
| 06/17/2004 | WO2004050643A2 Non-nucleoside reverse transcriptase inhibitors |
| 06/17/2004 | WO2004050642A1 1, 2, 3- triazole amide derivatives as cytokine inhibitors |
| 06/17/2004 | WO2004050638A1 Antibacterial agents |
| 06/17/2004 | WO2004050637A2 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors |
| 06/17/2004 | WO2004050636A2 IMIDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS |
| 06/17/2004 | WO2004050634A1 Indazole derivatives as crf antagonists |
| 06/17/2004 | WO2004050633A1 Pesticidal 1-ayl-3-amidoxime-pyrazole derivatives |
| 06/17/2004 | WO2004050632A1 Pyrazole derivatives useful as cox-i inhibitors |
| 06/17/2004 | WO2004050631A1 Substituted dihydrophenanthridinesul fonamides |
| 06/17/2004 | WO2004050630A1 The use of aryl- and heteroaryl-substituted tetrahydroisoquinolines in the treatment of chronic and neuropathic pain, migraine headaches, and urge, stress and mixed urinary incontinence |
| 06/17/2004 | WO2004050625A1 Resolution of mefloquine with o,o-di-p-aroyltartaric acid |
| 06/17/2004 | WO2004050624A1 Substituted 1h-pyridine-2-one derivatives |
| 06/17/2004 | WO2004050623A1 Methods for preparing phenylalkyne derivatives |
| 06/17/2004 | WO2004050619A1 Hydroxyethylamine derivatives for the treatment of alzheimer's disease |
| 06/17/2004 | WO2004050613A2 2-substituted-3-propenamide derivatives and methods of using the same |
| 06/17/2004 | WO2004050610A2 Modulators of melanocortin receptor |
| 06/17/2004 | WO2004050088A1 Jnk inhibitor |
| 06/17/2004 | WO2004050087A1 3-(2-hydroxy-phenyl)-1h-pyrazole-4-carboxylic acid amide derivatives as hsp90 inhibitors for the treatment of cancer |
| 06/17/2004 | WO2004050085A1 Aminoalkoxyindoles as 5-ht6-receptor ligands for the treatment of cns-disorders |
| 06/17/2004 | WO2004050039A2 Spirocyclic ureas, compositions containing such compounds and methods of use |
| 06/17/2004 | WO2004050035A2 Benzimidazoles and analogs thereof as antivirals |
| 06/17/2004 | WO2004050024A2 3-aminopyrrolidine derivatives as modulators of chemokine receptors |
| 06/17/2004 | WO2004049803A1 Pesticidal 5- (acylamino) pyrazole derivatives |
| 06/17/2004 | WO2004049797A2 Pesticidal sulphonylaminopyrazoles |
| 06/17/2004 | WO2004043463A3 Sulfonamides |
| 06/17/2004 | WO2004030611A3 Non-nucleoside reverse transcriptase inhibitors |
| 06/17/2004 | WO2004029204A3 Substituted pyrimidines |
| 06/17/2004 | WO2004014869A3 5,6-fused 3,4-dihydropyrimidine-2-one derivatives as matrix metalloproteinase inhibitors |
| 06/17/2004 | WO2004014316A3 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
| 06/17/2004 | WO2003105781A3 Ophthalmic compositions for treating ocular hypertension |
| 06/17/2004 | WO2003070184A3 Sodium channel blockers |
| 06/17/2004 | WO2003037308A8 Utilization of inhibitors of rho-kinases for stimulating nerve growth, inhibiting scar tissue formation and/or reducing a secondary lesion |
| 06/17/2004 | US20040116710 N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 06/17/2004 | US20040116707 4-Pyrrolidino-phenyl-benzyl ether derivatives |
| 06/17/2004 | US20040116706 Therapeutic ureas |
| 06/17/2004 | US20040116705 Synthesis method and intermediates of pyridin-2-yl-methylamine |
| 06/17/2004 | US20040116695 2-Mercapto-4,5-diarylimidazole derivatives and the use thereof as cyclooxygenase inhibitors |
| 06/17/2004 | US20040116518 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 06/17/2004 | US20040116507 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 06/17/2004 | US20040116501 Treatment of nonallergic rhinitis by selective phosphodiesterase 4 inhibitors |
| 06/17/2004 | US20040116497 Chromane derivatives, process for their preparation and their use as antitumor agents |
| 06/17/2004 | US20040116495 Compounds and methods |
| 06/17/2004 | US20040116491 Therapy for infections; autoimmune diseases; vision defects; asthma:eating disorders; cardiovascular disorders; liver disorders; antiallergens; antiinflammatory agents; antiulcer agnets |
| 06/17/2004 | US20040116490 Compounds and methods |
| 06/17/2004 | US20040116486 Metalloproteinase inhibitors |
| 06/17/2004 | US20040116480 Oxime ether compound and agricultural or horticultural bactericide |
| 06/17/2004 | US20040116477 2-Heteroaryl-3,4-dihydro-2h-pyrrole derivatives and the use thereof as pesticides |
| 06/17/2004 | US20040116476 Imidazolidinone compounds |
| 06/17/2004 | US20040116475 Nitrogen compounds such as N-(2-{4-[3-chloro-1-(4-methoxyphenyl)-1-H-pyrazol-5-yl]-phenoxy}ethyl)urea, used as cyclooxygenase inhibitors; analgesics; antiinflammatory agents |
| 06/17/2004 | US20040116474 Novel pyrazole compounds as transforming growth factor (TGF) inhibitors |
| 06/17/2004 | US20040116471 Indolylpiperidine derivatives as antihistaminic aand antiallergic agents |
| 06/17/2004 | US20040116469 Quinoline-4-carboxamide derivatives as NK-2 and NK-3 receptor antagonists |
| 06/17/2004 | US20040116465 Novel compounds |
| 06/17/2004 | US20040116462 Antiinflammatory agents |
| 06/17/2004 | US20040116457 Agents for improving excretory potency of urinary bladder |
| 06/17/2004 | US20040116454 Pyrazole compounds useful as protein kinase inhibitors |
| 06/17/2004 | US20040116452 Aminipiperidine compound; bactericides |
| 06/17/2004 | US20040116450 Antipruritics |
| 06/17/2004 | US20040116444 Psychological disorders, anxiety and stress disorders, antidepressants |
| 06/17/2004 | US20040116443 Dopamine D4 ligands for the treatment of novelty-seeking disorders |
| 06/17/2004 | US20040116440 Useful for diagnosis, treatment of male or female sexual dysfunction |
| 06/17/2004 | US20040116439 Serine protease inhibitors |
| 06/17/2004 | US20040116435 Benzimidazol derivatives modulate chemokine receptors |
| 06/17/2004 | US20040116430 Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade |
| 06/17/2004 | US20040116429 5-Phenylpyrimidines, methods and intermediate products for the production thereof and use of the same for controlling pathogenic fungi |
| 06/17/2004 | US20040116425 Prenylation inhibitors and methods of their synthesis and use |
| 06/17/2004 | US20040116424 Aryl imidazoles and related compounds as C5a receptor modulators |
| 06/17/2004 | US20040116423 5-Aryltetrazole compounds, compositions thereof, and uses therefor |
| 06/17/2004 | US20040116422 Drugs as enzyme inhibitors for tyrosine kinases and for treatment of psoriasis |
| 06/17/2004 | US20040116420 Remedial agent for viral infectious disease |
| 06/17/2004 | US20040116418 Compounds and methods for inhibition of HIV and related viruses |
| 06/17/2004 | US20040116417 Thiohydantoins and use thereof for treating diabetes |
| 06/17/2004 | US20040116416 having immunomodulating and cytokine-release-inhibiting action |
| 06/17/2004 | US20040116399 for preventing or treating coagulation disorders |
| 06/17/2004 | US20040116388 triazine compoound inhibitors of enzymes that catalyze phosphoryl transfer and/or that bind ATP/GTP nucleotides |
| 06/17/2004 | US20040116353 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 06/17/2004 | US20040115821 Sequestering proteins, peptides; determination concentration in mixture; analyzing by mass spectroscopy |
| 06/17/2004 | DE10256405A1 New 4-substituted quinoline derivatives, useful for treating bacterial infections, optionally including additional ring nitrogens |
| 06/17/2004 | DE10247233A1 New 4-substituted quinoline derivatives, useful for treating bacterial infections, optionally including additional ring nitrogens |
| 06/17/2004 | CA2508914A1 Modulators of melanocortin receptor |
| 06/17/2004 | CA2508581A1 Spirocyclic ureas, compositions containing such compounds and methods of use |
| 06/17/2004 | CA2508574A1 3-(2-hydroxy-phenyl)-1h-pyrazole-4-carboxylic acid amide derivatives as hsp90 inhibitors for the treatment of cancer |
| 06/17/2004 | CA2508329A1 Substituted dihydrophenanthridinesul fonamides |
| 06/17/2004 | CA2508325A1 Hydroxyethylamine derivatives for the treatment of alzheimer's disease |
| 06/17/2004 | CA2508319A1 Jnk inhibitors |
| 06/17/2004 | CA2508315A1 Aminoalkoxyindoles as 5-ht6-receptor ligands for the treatment of cns-disorders |
| 06/17/2004 | CA2507875A1 Methods for preparing phenylalkyne derivatives |
| 06/17/2004 | CA2507624A1 Imidazole-derivatives as factor xa inhibitors |
| 06/17/2004 | CA2507186A1 Anilinopyrazole derivatives useful for the treatment of diabetes |
| 06/17/2004 | CA2507074A1 Indazole derivatives as crf antagonists |
| 06/17/2004 | CA2506546A1 Kinase modulators |
| 06/17/2004 | CA2505945A1 Pyrazole derivatives useful as cox-i inhibitors |
| 06/17/2004 | CA2505893A1 Oxime ester photoinitiators with heteroaromatic groups |
| 06/17/2004 | CA2503146A1 Resolution of mefloquine with o,o-di-p-aroyltartaric acid |
| 06/16/2004 | EP1429147A1 Universal reagent for isotopically tagging peptides |
| 06/16/2004 | EP1428825A1 Benzimidazole derivatives |
| 06/16/2004 | EP1428824A1 Heterocyclic substituted aminoazacycles useful as central nervous system agents |